600511 國藥股份
按盤價 
29.600 -0.120 (-0.404%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.483 | 12.157 | 14.311 | 14.551 | 14.482 |
| 總資產報酬率 ROA (%) | 2.721 | 5.937 | 6.916 | 6.817 | 6.630 |
| 投入資產回報率 ROIC (%) | 4.309 | 9.453 | 11.294 | 11.487 | 11.621 | 邊際利潤分析 |
| 銷售毛利率 (%) | 6.138 | 7.106 | 8.031 | 8.401 | 7.814 |
| 營業利潤率 (%) | 4.795 | 5.292 | 5.925 | 5.923 | 5.267 |
| 息稅前利潤/營業總收入 (%) | 4.736 | 5.110 | 5.644 | 5.844 | 5.222 |
| 淨利潤/營業總收入 (%) | 3.868 | 4.209 | 4.697 | 4.679 | 4.150 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 80.920 | 82.663 | 85.365 | 84.828 | 86.605 |
| 價值變動淨收益/利潤總額(%) | 23.937 | 18.690 | 12.616 | 10.849 | 11.590 |
| 營業外收支淨額/利潤總額(%) | -0.207 | -0.897 | -0.460 | -0.262 | -0.101 | 償債能力分析 |
| 流動比率 (X) | 2.104 | 2.043 | 2.035 | 2.022 | 1.930 |
| 速動比率 (X) | 1.735 | 1.710 | 1.750 | 1.731 | 1.654 |
| 資產負債率 (%) | 44.410 | 45.674 | 45.974 | 46.437 | 48.749 |
| 帶息債務/全部投入資本 (%) | 13.665 | 19.178 | 15.012 | 16.498 | 14.208 |
| 股東權益/帶息債務 (%) | 595.315 | 396.060 | 531.600 | 472.573 | 563.460 |
| 股東權益/負債合計 (%) | 113.067 | 107.364 | 105.737 | 103.384 | 93.595 |
| 利息保障倍數 (X) | -97.454 | -38.006 | -22.238 | -92.200 | -132.292 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 95.030 | 75.737 | 53.260 | 45.326 | 43.226 |
| 存貨周轉天數 (天) | 38.381 | 34.149 | 30.242 | 31.237 | 27.584 |
| 備註： | 即時報價更新時間為 29/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
